We are live on ! Find out more
ARDS

Aridis Pharmaceuticals Inc. Common Stock
ARDS

Delisted

ARDS was delisted on the 18th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $1 invested in Aridis Pharmaceuticals Inc. Common Stock in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFCL
Strengthening Families & Communities LLC
Massachusetts
+$1

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SFCL
1
Strengthening Families & Communities LLC
Massachusetts
$1 +$1 +3,000 New

ARDS Hedge Fund Activity: Q1 2026 in Review

1 of the 8,136 institutional investors tracked by Wall St. Rank reported a position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) for Q1 2026, worth a combined $1.

Buyers outnumbered sellers: 1 fund opened new ARDS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Strengthening Families & Communities LLC, opening a new position worth an estimated $1.

  • 1 institutional investor held Aridis Pharmaceuticals Inc. Common Stock (ARDS) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $1 of Aridis Pharmaceuticals Inc. Common Stock stock for Q1 2026.
  • 1 fund opened new Aridis Pharmaceuticals Inc. Common Stock positions in Q1 2026 and 0 closed out, a net change of +1 holder.
  • The largest Aridis Pharmaceuticals Inc. Common Stock buyer in Q1 2026 was Strengthening Families & Communities LLC, an estimated $1 added.

Based on aggregated 13F filings for Q1 2026.